In acute myocardial infarction, variables such as advanced age, anterior myocardial infarction, extent of clectrocardiographic (ECG) changes, evidence of acute left heart failure and history of previous infarction or diabetes mellitus all identify patients at higher risk of death (1, 2) . However, for early clinical decision making it would be much more important to be able to identify within a particular risk group the individual patient with a relatively good or an exceptionally unfavorable prognosis. Ideally, such early assessment should be simple, quick, noninvasive and easy to use in all patients with evolving myocardial infarction .
Findings from a study of EC6 prediction of coronary artery patency after thrombolytic therapy suggested that the amount of early resolution of ST segment elevation might be Results. For complete, partial and no ST segment resolution 3 h after the start of streptokinase or placebo infusion, enzyme release was 1 .2, 1 .8 and 2.1 IU/nd x h; number of Q waves 1 .7, 2 .5 and 3 .0; and ejection fraction 60%, 53% and 49%, respvcs tively (all adjusted p = 0 .0000). Mortality rate at 21 days was 2 .2%, 3.4% and VIA% respeedvely. No ST segment resolution was the most powerful independent predictor of early mortality (p = 0.001) . Survival rate curves at 6-year follow-up showed significant mortality differences with increasirig divergence (p = COOK03 anterior infarction; p = 0 .00 inferior infarction) . In subgroups with an overall higher risk of dying, morWity was st®roangly determined by the extent of early ST segment resolution .
Conclusions. The extent of ST segment elevation resolution conveys useful early information about outcome In an individual patient after acute myocardial infarction .
(J Am Cell Cardio 1"4;24.384-91) JACC Vol . 24, No. 2 August 1994 :384-91 a useful prognosticator (3) . In contrast to other ST segment markers with a higher sensitivity for coronary perfusion, resolution of ST segment elevation z70% at 3 h after the start of thrombolytic therapy was a major predictor of favorable outcome (3) . However, it appeared clinically meaningful not only to distinguish patients with a favorable outcome (ST segment resolution L-707b) but also those who couldd be expected to have a poor prognosis . According to a study by Saran et al . (4) , <30% ST segment resolution appeared to be a useful cutoff point for predicting a particularly unfavorable outcome. Accordingly, we performed a prospective study in 77 patients with acute myocardi-0 infarction and thrombolysis within 6 h after symptoin ST segment resolution, as measured by the two cutoff points (ST segment resolution a-7017c and <30%), at 3 h after the start of thrombolysis significantly predicted enzy , 7natic infarct size and angiographic left ventricular function (5) . We therefore proposed to verify the prognostic power of these different amounts of ST segment resolution ~, agog data from the Intravenous Streptokinase in Acute ocardial Infarction (ISAM) (6) study data base, which provides a large, well characterized patient group for whom m .ultivari-0105-109W907.00 ate analyses can be performed to identify independent determinants of mortality .
Methods
Study population . The ISAM study was a double-blind, placebo-controlled German-Swiss-Canadian multicenter trial in which streptokinase therapy revealed significant limitation in enzymatic infarct size, better global and regional ejection fraction I month after infarction and a trend toward reducedd mortality (6, 7) . Between March 1982 and March 1985, 1,741 patients <76 years of age were randomly allocated to receive either 1 .5 MU of streptokinase or placebo infusion . Immediately after randomization, streptokinase or placebo infusion was started, combined with a bolus injection of 5,0M IU of heparin and 0 .5 g of acetylsalicylic acid and followed by heparin infusion continued for 72 to 96 h with overlapping phenprocoumon treatment for at least 3 weeks . A 12-lead ECG was recorded before and 3 h after randomization . Evolving myocardial infarction was diagnosed when typical symptoms and ST segment elevation of at least 0.1 mV in two limb leads or 0.2 mV in two contiguous chest leads were present .
Of the 1,741 randomized patients, 225 had to be excluded from the present analysis : 20 patients died within 3 h after randomization or had cardiac arrest and died shortly thereafter ; 120 patients had bundle branch block or ventricular rhythm (mostly pacing), 30 of whom died within 21 days . Of the remaining 85 patients, 48 had no significant ST segment elevation in their prerandomization ECG (sum of ST segment elevation <2 mm), and 37 patients (2%) had no available ECG 3 h later . Of these 85 patients, 5 died within 21 days . Therefore . 1,516 study patients comprised all patients eligible for thrombolytic therapy : :56 h of onset of myocardial infarction symptoms, who had no bundle branch block and survived the 1st 3 h after hospital admission .
Electrocardiographic analysis . The sum of ST segment elevation was measured 20 ms after the end of the QRS complex from leads 1, aVL and V1 to V6 for anterior and leads 11, 111, aVF and V5 to V6 for inferior myocardial infarction . ST segment depression was not measured . The development of new Q waves (Minnesota code criteria) was calculated from the difference from the number of leads with Q waves in the prerandomization ECG and that 3 weeks later M. All measurements were performed at a core laboratory that had no knowledge of treatment assignment or outcome . The first ECG was recorded before randomization, on average 72 min after admission (prerandomization or baseline ECG), and the second ECG 3 h after the start of streptokinase or placebo infusion, which was initiated immediately after randomization .
Enzyme analysis . Creatine kinase isoenzymes, MB fraction (CK-MB), serum activity was measured in 2-h intervals . The enzyme infarct size was calculated from the area under the curve . The time to peak CK-MB activity was measured SCHRODER ET AL .
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AMOUNT OF ST SEGMENT RESOLUTION PREDICTS OUTCOME by the interval between the start of treatment and maximal serum CK-MB activity (6) , Quantitative angiographic analysis . Analysis of global ejection fraction and regional dyssynergic area of the left ventricle related to the infarct-related artery was performed in 818 patients I month after infarction (6) . Patients who had angiography were younger than those who did not (55 vs . 62 years) ; 45% who had angiography had anterior infarction ; 50% had streptokinase therapy ; and 49% had complete, 31% partial and 20% no ST segment resolution .
Follow-up. During the 1st 7 months, all critical events, including reinfarction, were reviewed by an independent critical event committee . Follow-up >7 months concerned total mortality only, evaluated by inquiries based on the government's registry . At a cutoff date of August 31, 1986, no vital status could be obtained for six patients . After August 1986 the remaining 132 Canadian patients were no longer followed up . For 79 patients the 2-year follow-up was not completed at that time . At the final cutoff date of August 31, 1991, only 17 of the German and Swiss patients were lost 10 follow-up, Prognostic ST segment resolution groups. During clinical routine use of the extent of ST elevation resolution as a prognostic marker it had become obvious that for slight ST elevation, measures of percent resolution were imprecise and impracticable . Because these patients usually have a good prognosis, for purposes of this analysis they were included in the group of patients with complete ST segment resolution : 1) Complete resolution was defined as resolution of the initial sum of ST segment elevation ?70% 3 h after randomization or only slight ST segment elevation (sum of ST segment elevation at baseline 0 .2 to 0 .4 mV for anterior ischemia and 0 .2 mV for inferior ischemia and at least no increase 3 h later) ; 2) partial resolution as ST segment resolution <70% to 30% ; and 3) no resolution as ST segment resolution <30% to >0% .
Statistical analysis . Univariate analyses of differences between ST segment resolution groups were performed using one-way analysis of variance (ANOVA) (F tests) for continuous outcome variables and Pearson chi square tests with Yates correction for discrete outcome variables (mortality) .
For all multivariate analyses, a combination of 10 dichotomous or dichotomized baseline factors, in addition to ST resolution, were used as covai0s : 1) age a65 years, 2) male gender, 3) anterior myocardial infarction, 4) evidence of acute left heart failure (pulmonary rates or pulmonary conges tion , or both. on chest X-ray film), 5) history of congestive heart failure, 6) previous myocardial infarction, 7) angina pectoris >4 weeks before infarction, 8) diabetes mellitus, 9) treatment with streptokinase, and 10) baseline sum of ST segment elevation > 1 .2 mV for anterior infarction and >0 .6 mV for inferior myocardial infarction, respectively (large sum of ST segment elevation) .
A fixed-effect multiway ANOVA was performed for three continuous outcome variables using the 10 baseline factors and the three ST segment resolution groups as additional factors, with no interactions admitted . From these analyses we report the adjusted mean values for the three ST segment resolution groups and the p values for the corresponding F test. For overall mortality at 21 days, 2-and 5-year logistic regressions were performed using the same 10 baseline factors and the three ST segment resolution groups as an additional factor with no interactions admitted . The adjusted odds ratios, confidence intervals and p values are reported . In addition, analyses with two ST segment resolution groups (cutoff points 30% or 70%, respectively) were repeated . The raw and adjusted odds ratios for all significant factors with a cutoff point at 30% are also reported . Survival curves for the three ST segment resolution groups were then estimated according to Kaplan-Meier; comparisons were made using the log-rank statistic . Calculations were made using the procedures ONE WAY, ANOVA and logistic regression of SPSSPC, Version 4.0, and the procedures PLR and PIL of the mainframe version of BMDP.
Results

Study pu
Ls (Table 1) . Of the 1,516 ISAM study patients with significant ST segment elevation and initiation of study drug infilsion within 6 h after onset of acute myocardial infarction symptoms, the ECG recorded 3 h after the start of streptokinase or placebo infusion revealed in 45% of patients complete ('70%), in 31% partial (<70% to 30%) and in 24% no resolution (<30% to >0%) of their initial ST elevation on the prerandomization ECG . The group with complete resolution included 127 patients with only slight ST segment elevation, as defined earlier (50 with anterior, 77 with inferior ischemia ; only I of these 127 patients died within 21 days) .
Patients with no ST segment resolution were slightly older, and the proportion of patients with diabetes was nearly twice that in the other groups. Infarct location was unevenly distributed . In the group with complete ST segment resolution, about two-thirds of patients had an inferior infarction, and one-third had an anterior infarction ; in the no-resolution group, this was reversed . The time intervals from treatment start to maximal serum CK-MB activity were significantly different among the three groups (11 .9 ± 5, 14 .2 6 and 15 .8 ± 6 h, respectively, p = 0.1111) .
Infarct size, left ventricular function and 7-month reinfarction (Tables 2 and 3 ) . The adjusted, actual infarct size, as measured from the areas under the CK®MB serum activity curves and the number of Q waves as well as ejection fraction I month after infarction were significantly better with complete than with partial, and better with partial than with no, ST segment resolution . As shown in Table 3 , the outcome with either infarct location was similarly beneficial with complete ST segment resolution, whereas the extent of the increasingly worse outcome from complete (to partial and) to no ST segment resolution was greater in anterior myocardial infarction . New Q waves and angiographic infarct size were more than twofold with no, compared with complete, ST segment resolution . However, in patients with an inferior infarct location, the reinfarction rate was significantly higher with complete ST segment resolution . Short . and long-term mortality rates (Table 4 , Fig . 1 ) .
Overall mortality rates at 21 days and 2 and 5 years and adjusted relative risks of dying between complete and partial and complete and no ST segment resolution, respectively, were highly significantly different . The actuarial curves for survival with 6-year follow-up in Figure 1 for anterior and inferior infarction show highly significantly mortality differences among the three groups, with increasing divergence, particularly for partial ST segment resolution in anterior infarction . With complete ST segment resolution, long-term mortality was similarly low with either infarct location . Prognostic impact of the extent of ST segment resolution in risk subsets (Table 5 ), The 2-year mortality rates by clinical variables, identified to be independent predictors of survival, are subdivided by the three groups of ST segment resolution in Table 5 . There were relatively minor differences in all patients with an initially small or large extent of ST segment elevation (2-year mortality rate 11 .3% and 14 .4%, respectively), but those with complete ST segment resolution 3 h later had less than half the mortality risk (6 .5% and 9.9%, respectively) than those with no ST segment resolution (19 .0% and 22 .8%, respectively) . Thus, the initial extent of ST segment elevation is less relevant than the amount of SCHWDER ET AL .
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AMOUNT OF ST SEGMENT RESOLUTION PREDICTS OUTCOME *All patients with anterior or inferior infarction (F test p values) . tOn the baseline (Prerandoinization) electrocardiogram . Data presented are mean value SD or number (%) of patients (pis) . DA = dyssynergic area of the left ventricle ; other abbreviations as in Table 2 .' resolution afterward . Accordingly, for each risk subset mortality varied considerably in relation to the awount of early ST segment resolution . For example, a patient with reinfaretion and no ST segment resolution had a mortality risk rate of 46016, whereas it was only 13% with complete ST segment resolution .
Thrombolyfic therapy (Fig. 2) . The power to predict infarct size and mortality from the amount of ST segment resolution was the same regardless of whether patients had been allocated to streptokinase or placebo infusion . In the groups with complete, partial or no ST segment resolution, CK-MB serum activity curves in streptokinase group patients were, respectively, 1 . 3, 1 .8 and 2 .0 IIJ/H x h, and in placebo group patients 1 .2, 1 .9 and 2 .1 Mini x h ; left ventricular ejection fraction was 60%, 55% and 50% versus 60%, 52% and 48%, respectively ; and 2-year mortality risk rate was 8 .9%, 13 .4% and 19 .7% versus 6 .9%, 13 .9% and 21 .4%, respectively .
ThL percent of patients with complete, partial or no ST segment elevation was significantly different between streptokinase-treated and placebo-treated patients (p = 0-M). The percent of patients with complete ST segment resolution was greater in the streptokinase group compared with the placebo group, and there were fewer patients with persistent ST segment elevation with thrombolytic therapy .
Mulitiv to analysis with one ST t resolution cutoff point (Table 6 ) . With a cutoff point at 30%, multivariate logistic regression analysis revealed four covariates that were independent predictors of 21-day mortality . The adjusted odds ratios ranged from 2 .9 for <30% ST segment resolution to 1 .8% for large ST segment elevation on the baseline ECG . For long-term mortality at 2 years advanced age became the best single predictor, whereas previous myocardial infarction, evidence of acute left heart failure and a history of diabetes were added as independent risk factors. ST segment elevation resolution <30% remained an independent significant predictor of death, with an odds ratio of 1 .9 at 2 years . For an ST segment resolution cutoff point at 70% (i.e ., complete ST segment resolution group), the adjusted odds ratio for 21-day mortality was 2 .1 (95% confidence interval [CI] 1 .2 to 4 .0) and for 2-year mortality 2 .0 (95% CI 1 .4 to 2 .8) . 
Discussion
In patients with acute myocardial infarction, several variables associated with an increased mortality risk can be evaluated within minutes of the patient's arrival at the hospital (1,2) . The present analysis confirmed older age, previous infarction, clinical evidence of acute left heart failure, diabetes, anterior myocardial infarction and greater extent of initial epicardial injury to be independent prognosticators of increased mortality . However, for early clinical decision making the presence or absence of these risk factors appeared to be of little actual relevance . None of them alone would probably change clinical routine management decisions in individual patients .
In contrast, the extent of early resolution of ST segment elevation in patients with evolving myocardial infarction <6 h in duration strongly discriminates individual patients with a favorable outcome from those with a poor one . The most important result from the present analysis is the finding that for all clinical variables the risk modification due to the amount of early ST segment resolution is striking (Table 5) , Except for diabetes, high risk patients with complete ST segment resolution always have a better long-term outcome than patients without that particular risk but with no ST segment resolution.
We defined three groups according to complete (~70%), partial (<70% to 30%) and no (<30% to >0%) ST segment resolution to differentiate patients with a very good prognosis from those with a particularly poor one, leaving an intermediate group . Because patients presenting with only slight ST segment elevation at hospital admission and at least no increase in ST segment elevation 3 h later comprise a good risk group in itself, they were included in the group with complete ST segment resolution . The predictive power of these three groups in terms of infarct size, left ventricular function and survival is surprisingly strong regardless of whether patients have had streptokinase treatment . A beneficial effect of thrombolytic therapy is related to a larger proportion of patients with complete ST segment resolution and less with persistent ST segment elevation (Fig . 2) .
Using multivariate logistic regression with ST segment resolution dichotomized at a cutoff point of 30%, we identified seven factors that were independently associated with increased mortality . The most powerful predictor of 21-day mortality was the absence of a reduction ?30% in ST segment elevation (i .e., no ST segment resolution) . As expected, during long-term follow-up, age became the factor of overriding prognostic importance . However, lack of early ST segment resolution remained a good discriminator after age and previous myocardial infarction at 2-year follow-up (Table 6 ) . Changing the ST segment resolution cutoff point from 30% to 70%® for 21-day mortality resulted in a smaller odds ratio, indicating that for short-term mortality the partial ST segment resolution group is closer to the complete ST segment resolution group than to the no ST segment resolution group. However, at 2-year follow-up both complete and Table S no ST segment resolution were identified as independent predictors of mortality with almost identical power . Mechanisms of ST segment elevation resolution. There is no evidence to suggest that patients with no ST segment resolution might have had a larger infarct . On the contrary, the extent of the initial epicardial injury, as measured by the sum of ST segment elevation, was significantly smaller in patients with an anterior myocardial infarction with no ST resolution (Table 3) , reflecting potentially even smaller infarcts (7) .
There is still controversy about the usefulness of early ST segment changes as a marker of reperfusion (3) (4) (5) (8) (9) (10) . Hgare 2 . Percent of patients with complete, partial or no ST segment resolution at 3 h after randomization for all patients and those allocated to receive streptokinase or placebo . ST 00% <70-300/6 -300/6 SCHRODER ET AL . AMOUNT OF ST SEGMENT RESOLUTION PREDICTS OUTCOME 389 However, there is consensus that ST segment elevation resolution in the range ?709b' is associated with infarctrelated artery patency from drug-induced or spontaneous reperfusion (3, 5, (8) (9) (10) . Complete ST segment resolution a70% was present in 54% of our thrombolysis group patients and in 36% of our placebo group patients as well (Fig . 2) , which may reflect spontaneous reperfusion during anticoagulation (11, 12) .
Absence of at least 30% ST segment resolution at 3 h after thrombolysis will be highly specific (albeit less sensitive) for lack of reperfusion (3) (4) (5) 8, 9) . Although most patients with partial ST segment resolution achieve reperfusion (3) (4) (5) 8, 9) , they develop larger infarcts (5) . This refers particularly to patients with initially complete occlusion of the proximal left anterior descending coronary artery without good collateral vessels, who often show transient additional ST segment elevation at the time of reperfusion (13, 14) .
Continuous ST segment monitoring and serial coronary angiography have shown that spontaneous intermittent recanalization and reocclusion with corresponding ST segment shifts are frequent during the early phase of myocardial infarction (15, 16) . However, the strong predictive power of ST segment resolution measured at a fixed interval of 3 h after the start of streptokinase or placebo infusion suggests no major interference with ST segment fluctuations . In the preceding study (5), a 12-lead ECG was recorded every 5 min . Of those patients with complete ST segment resolution 3 h after initiation of thrombolysis, 26% had ST segment fluctuations after an initial resolution . They had a favorable outcome, similar to those patients without early ST segment fluctuations (5) . Clinical IM . The extent of early ST segment elevation resolution as a prognostic indicator has been addressed in three previous studies . Richardson et al . (17) found that an abrupt reduction in ST segment elevation within the 1st 3 h after the start of thrombolysis was strongly predictive for an open infarct-related coronary ante : y ; however, sensitivity was lower, and left ventricular function was equally impaired, with and without abrupt ECG changes . Saran et al . (4) used a cutoff point of 30% ST segment resolution at 3 h, and Barbash et al . (18) used 50% resolution at l h after the initiation of thrombolytic therapy . In both studies a lesser de of ST segment elevation resolution was associated with a significantly worse outcome . However, both studies had the limitation that the "good risk" groups with more ST segment resolution included too many patients with still severely depressed left ventricular function .
Applying two cutoff points of ST segment resolution can solve these problems . Complete ST segment resolution allows identification of a large subset of patients with excellent survival . However, they carry a slightly higher probability of nonfatal reinfarction . An appropriate predischarge stress test may identify those patients who could additionally benefit from early angiography and revascularization maneuvers . Patients with anterior infarction and only partial ST segment resolution despite reperfusion have an increasing mortality risk over the long term (Fig . I) and may benefit most from more vigorous adjunctive pharmacotherapy . Lack of ST segment resolution identifies patients who have a poor prognosis without reperfusion and in whom reperfusioa might be expected to provide substantial benefit . These patients may be candidates for immediate coronary angiography and rescue percutaneous transluminal coronary angio- (20) . However, whether and which patients will benefit from early intervention is still a matter of debate (11,21) . Benefit may be expected, especially in patients with a particularly high mortality risk, such as those with recurrent infarction (22) . However, in diabetic patients without previous infarction a conservative strategy might be preferable . In these patients invasive procedures had been shown to be associated with increased mortality (22) . In this respect it is noteworthy that patients with diabetes in this study comprise the only risk group in which mortality remained high regardless of complete ST segment resolution (Table 5) .
Study limitations . Although we had first performed a prospective, small study that established the predictive value of the three ST segment resolution groups with similar results (5), the current study is a retrospective analysis . Adding 127 patients (8%) with only slight ST segment elevation to the group with complete ST segment resolution is data derived. However, this was done only because it is clinically reasonable and meaningful . Complete ST segment resolution was measured in 50 patients, partial resolution in 42 and no resolution in 35 patients . Reevaluation of all data with these patients in their respective groups changed virtually no result . Moreover, to ensure that the special composition of the complete ST segment resolution group did not violate the fundamental basic hypothesis of a good prognosis in patients with complete ST segment resolution, the data were reanalyzed after complete removal of the cohort of 127 patients with slight ST segment elevation . Again, the results were almost unchanged . Compared with Table 2 [CIA-MB se!-~-n activity curves 1 .3 ± 1 .1 Urni x h ; new Q waves 1 .8 ± 1 .4 ; ejection fraction 60 ± 101) .
We did not intend to evaluate the prognostic use of various risk factors per se in patients with evolving myocardial infarction . Therefore, no statistical adjustment was attempted for the 50 deaths occurring in patients who either died before the 3-h ECG (most were in cardiogenic shock) or had significant conduction disturbances . Rather, the aim of the analysis was to estimate within the various clinical variables the individual risk of a particular patient not already otherwise identified to carry a high risk of d~ing because of the presence of cardiogenic shock or bundle branch block . In this regard differences in baseline characteristics, such as slightly older age and a higher proportion of diabetic patients in the no-ST segment resolution group, are less relevant .
Conclusions. Retrospective analysis of a large, well characterized patient group showed that the amount of ST segment resolution 3 h after the start of streptokinase or placebo infusion conveys useful information about the outcome of patients with acute myocardial infarction regardless of whether they were treated with thrombolysis . In the preceding study (5), the predictive power of the ECG markers had been superior to that of the reperfusion state alone, as assessed noninvasively by an early abrupt increase in serum CK activity measured in 15-min i ntervals . ST segment resolution ?M predicts not only reperfusion but also the development of small infarcts . These patients have a low short-and long-term mortality rate . The group with ST segment resolution <30% includes not only patients with persistent vessel occlusion but also those in whom lack of reperfusion is associated with the development of large infarcts and, accordingly, high short-and long-term mortality rates . In patients with an overall higher risk of dying, mortality rate is strongly determined by the extent of early ST segment resolution .
The predictive power of the simple, noninvasive early marker of prognosis, easy to use in all patients who do not have a bundle branch block and who survive 3 h after hospital admission, seems extraordinarily strong . Just two 12-lead ECGs, one recorded at hospital admission, the other 3 h later, may be helpful for a timely triage of patients to appropriate therapeutic interventions .
